The peptide industry has long faced the dilemma of "easy small-scale testing and difficult mass production". Laboratory qualified peptide products often suffer from problems such as decreased purity, uneven batches, and low yields in industrial scale production, which seriously restricts the commercialization of peptide drugs and raw material products. To break the bottleneck of mass production, professional synthetic peptide manufacturers continue to optimize their production system and create an industrial platform that integrates research and development, customization, large-scale production, and technical support. The enterprise upgrades its fully automated large-scale production equipment, establishes a standardized production control system, accurately controls the entire production process such as feeding, synthesis, purification, and freeze-drying, effectively solves the problem of process instability in mass production, and ensures the consistency of each batch of products. At the same time, we will establish a dedicated mass production technology team to provide customized technical services such as process optimization, parameter debugging, and risk prevention to meet the needs of customers for pilot scale amplification and commercial production. We will connect the complete chain from small-scale research and development to large-scale production, and provide solid production capacity and technical support for the commercial application of peptides.